Skip to main content

Table 4 Chi-Square tests for LOP and HOP tests by Hospital admission, ICU admission, and death

From: Quantification of pulmonary opacities using artificial intelligence in chest CT scans during SARS-CoV-2 pandemic: validation and prognostic assessment

Variables

N of Valid cases

Pearson Chi-Square

Fisher’s Exact Test

Value

Asymptotic Significance (2-sided)

Exact Sig. (2-sided)

LOP test * Hospital admission (COVID-19 negative group)

129

22.617a

< 0.001

< 0.001

LOP test * Hospital admission (COVID-19 positive group)

175

43.957b

< 0.001

< 0.001

HOP test * Hospital admission (COVID-19 negative group)

129

31.526a

< 0.001

< 0.001

HOP test * Hospital admission (COVID-19 positive group)

175

36.504a

< 0.001

< 0.001

LOP test * ICU admission (COVID-19 negative group)

125

1.347b

0.246

0.351

LOP test * ICU admission (COVID-19 positive group)

170

12.683a

< 0.001

< 0.001

HOP test * ICU admission (COVID-19 negative group)

125

4.528a

0.033

0.046

HOP test * ICU admission (COVID-19 positive group)

170

18.229a

< 0.001

< 0.001

LOP test * death (COVID-19 negative group)

125

0.795b

0.373

0.512

LOP test * death (COVID-19 positive group)

170

2.475b

0.116

0.209

HOP test * death (COVID-19 negative group)

125

1.440a

0.230

0.367

HOP test * death (COVID-19 positive group)

170

7.989a

0.005

0.003

  1. Significance values lower than 0.05 are shown in bold
  2. LOP:low opacity; HOP:high opacity; PCR:Polymerase Chain Reaction; ICU:Intensive Care Unit
  3. a0 cells (0.0%) have an expected count of less than 5
  4. bAt least 1 cell has an expected count of less than 5. In this case, Fisher’s Exact Test value was used